MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+6.37%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$485M
AUM Growth
+$485M
(+4.3%)
Cap. Flow
-$781K
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$2.3M |
| 2 |
iShares MSCI India ETF
INDA
|
$998K |
Top Sells
| 1 |
Alkermes
ALKS
|
$4.08M |
Sector Composition
| 1 | Healthcare | 95.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $314M | 64.69% | 15,966,038 | – | – |
|
|
2
Esperion Therapeutics
ESPR
$448M
| $123M | 25.39% | 2,679,835 +50,000 | +2% | +$2.3M |
|
|
3
Alkermes
ALKS
$4.78B
| $26.3M | 5.42% | 892,400 -138,239 | -13% | -$4.08M |
|
|
4
iShares MSCI India ETF
INDA
$9.17B
| $10.6M | 2.19% | 320,000 +30,000 | +10% | +$998K |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $9.92M | 2.04% | 400,000 | – | – |
|
6
Celldex Therapeutics
CLDX
$1.47B
| $1.25M | 0.26% | 6,312,700 | – | – |
|